Search Our Funded Studies

Restoring Excitation-Inhibition Balance in Alzheimer’s Disease Mouse Models

Moustafa Algamal, Ph.D.
Boston, MA - United States
2023

Undiagnosed Dementia in Hospitals: Prevalence, Risk Factors, and Outcomes

Márlon Aliberti, M.D., Ph.D.
Sao Paulo, Brazil
2023

Influence of the Microenvironment on the Turnover of Fluid Biomarkers

Tatiana Alvarez Giovannucci, Ph.D.
London, United Kingdom
2023

Targeted Network Attack in Assessing Brain Resilience

Georgette Argiris, Ph.D.
New York, NY - United States
2023

The Role of Astrocytic Tau Deposition onto Synaptic and Memory Dysfunction

Eleni-Kostania Argyrousi, Ph.D.
New York, NY - United States
2023

Assessing Meaningful Engagement in Advanced Dementia (MEAD)

Arlene Astell, Ph.D.
Toronto, Canada
2023

AD Nanomedicines Targeting Vasculature Disfunction and Neuroinflammation

Giuseppe Battaglia, Ph.D.
Barcelona, Spain
2023

Determining the Impact of Tau Aggregates on Neuron Loss with 2P Imaging

Rachel Bennett, Ph.D.
Boston, MA - United States
2023

Uncovering Mechanisms of Neuronal Hyperexcitability in Tauopathies

Steven Boggess, Ph.D.
San Francisco, CA - United States
2023

Nanotau

Luc Buée, Ph.D.
Lille, France
2023

Uncovering Mechanisms of Axonal Pathology in Alzheimer's disease

Yifei Cai, Ph.D.
New Haven, CT - United States
2023

Continued Development of the Next Generation Environmental Assessment Tool

Margaret P Calkins. Ph.D.
Cleveland Heights, OH - United States
2023

Mechanisms of Gamma-Secretase Modulators, Towards Rational Drug Design

Lucía Chávez-Gutiérrez, Ph.D.
Gent, Belgium
2023

MEG Predictors of Social Learning in Early AD and Behavioral-Variant FTD

Yu Chen, Ph.D., MPH
San Francisco, CA - United States
2023

Alzheimer’s Disease and Related Dementias in Gender Minority Adults

Ethan Collin Cicero, Ph.D.
Atlanta, GA - United States
2023

Can Subtyping of Alzheimer’s Heterogeneity Improve Clinical Trial Design?

Lyduine Collij, Ph.D.
Amsterdam, Netherlands
2023

ApoE Lipid Transport by ABCA7 Genetic Variants

Jamaine Davis, Ph.D.
Nashville, TN - United States
2023

A Novel Item-Level Category Fluency Scoring to Detect AD at the MCI Stage

Matteo De Marco, Ph.D.
Uxbridge, United Kingdom
2023

Sleep and AD Risk Among Older African Americans

Darlingtina Esiaka, Ph.D.
Newark, NJ - United States
2023

Cerebrovascular Pathology Across the Alzheimer's Ccontinuum in Down syndrome

Lisi Flores Aguilar, Ph.D.
Irvine, CA - United States
2023

SUMO2 Protein Replacement Therapy to Counteract Tau Toxicity in AD

Paul E. Fraser, Ph.D.
Toronto, Canada
2023

Leveraging Longitudinal Cohort Data to Assess Sleep as a Risk Factor for AD

Kelsie Full, Ph.D.
Nashville, TN - United States
2023

Comprehensive Multi-Neuron Imaging of Neurodegeneration in C. elegans

Christopher Gabel, Ph.D.
Boston, MA - United States
2023

Data Integration Strategies to Study Gene Expression in Alzheimer's Disease

David Gate, Ph.D.
Chicago, IL - United States
2023

Person-Centered Outcome Measures for AD Patient Emergency Care Experiences

Andrea Gilmore-Bykovskyi, Ph.D.
Madison, WI - United States
2023

Multimodal Models for Triage of Cognitive Decline and AD Pathology

Joseph Giorgio, Ph.D.
Berkeley, CA - United States
2023

Cognitive Reserve in Latin America: Evidence from Mexico and Brazil

Natlia Gomes Gonçalves, Ph.D.
Sao Paulo, Brazil
2023

Alcohol Use and APOE Genotype in Alzheimer's Disease Risk

Danielle Gulick, Ph.D.
Tampa, FL - United States
2023

Cortico-Hippocampal Dysfunction in the Progression of Alzheimer's disease

Melissa Hernandez Frausto, Ph.D.
New York, NY - United States
2023

Role of Astrocytes in Microglia-Synapse Engulfment

Soyon Hong, Ph.D.
London, United Kingdom
2023

1 2 3 4 5 6 7 8 9 10... >|